BioPharmSignal logoBioPharmSignal

Biotech News

RxSight, Inc. to Report First Quarter 2026 Financial Results on May 6

RxSight (RXST)RxSightEarnings

ALISO VIEJO, Calif., April 22, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., today announced that it will report financial results for the first quarter after the market close on Wednesday, May 6, 2026. The company’s management will discuss the results during a conference call beginning

Open original release

Related news

RXSTRxSight2026-05-06 20:05 EST

RxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlook

ICCMIceCure Medical2026-05-06 12:30 EST

IceCure Medical to Report First Quarter 2026 Financial and Operating Results on May 12, 2026

IRIXIRIDEX2026-05-05 20:05 EST

Iridex to Report First Quarter 2026 Financial Results on May 19, 2026

CVRXCVRx2026-04-27 20:30 EST

CVRx to Report First Quarter 2026 Financial and Operating Results and Host Conference Call on May 11, 2026

OMOutset Medical2026-04-27 20:05 EST

Outset Medical to Report First Quarter 2026 Financial Results on Thursday, May 7, 2026

TMCITreace Medical Concepts2026-04-24 11:05 EST

Treace to Report First Quarter 2026 Financial Results on May 8, 2026

SGHTSight Sciences2026-04-21 20:05 EST

Sight Sciences to Report First Quarter 2026 Financial Results on May 6, 2026

ADPTAdaptive Biotechnologies2026-04-15 20:05 EST

Adaptive Biotechnologies to Report First Quarter 2026 Financial Results on May 5, 2026

XTNTXtant Medical2026-05-07 12:00 EST

Xtant Medical to Announce First Quarter 2026 Financial Results on May 13, 2026

HYPRHyperfine2026-04-28 20:05 EST

Hyperfine, Inc. to Announce First Quarter 2026 Financial Results on May 12, 2026

View all latest news

RxSight

RxSight is a medical device company focused on adjustable intraocular lenses for cataract surgery. Its business is built around ophthalmic procedure adoption and premium eye-care technology.

Recent company news

RXSTRxSight2026-05-19 20:10 EST

RxSight, Inc. to Present at the Stifel 2026 Virtual Ophthalmology Forum

RXSTRxSight2026-05-06 20:05 EST

RxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlook

RXSTRxSight2026-04-29 20:10 EST

RxSight, Inc. to Present at the Bank of America Healthcare Conference

RXSTRxSight2026-04-22 20:10 EST

RxSight, Inc. to Report First Quarter 2026 Financial Results on May 6

RXSTRxSight2026-04-08 20:05 EST

RxSight Highlights 300,000 Light Adjustable Lens Implant Milestone and Strong Scientific Presence at ASCRS 2026

Stock data

Close
5.64 USD
Market cap
204.5M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States